Search
Search Results
##search.searchResults.foundPlural##
-
RECENT ADVANCES IN THE 5Q- SYNDROME
2953PDF: 1892HTML: 3814Pellagatti Fig 1: 245Pellagatti Fig. 2: 239 -
-
DRUG THERAPY IN THE PROGRESSED CML PATIENT WITH MULTI-TKI FAILURE
277810PDF: 1849HTML: 3898 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1441PDF: 1297HTML: 515 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4458PDF: 1799HTML: 1122 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1655PDF: 1102HTML: 467 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1364PDF: 809HTML: 361 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1951HTML: 1648PDF: 1152 -
SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
2337PDF: 943HTML: 2219 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
4610PDF: 1781HTML: 1217 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
1906PDF: 1147HTML: 10750Untitled: 212 -
COEXISTENCE OF MULTIPLE GENE VARIANTS IN SOME PATIENTS WITH ERYTHROCYTOSES Multiple gene variants in erythrocytosis
918PDF: 1278HTML: 145 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2928PDF: 1052HTML: 5639 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
3258PDF: 643Suppl. Files: 302HTML: 276 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2908PDF: 1186HTML: 11416 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1945PDF: 1037HTML: 243 -
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN
3396PDF: 901HTML: 1163Cover: 205 -
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2153PDF: 803HTML: 3255 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3347PDF: 1511HTML: 5966Fig1-Ag-Pil: 259Ag-Pil Fig.2: 259 -
Antivirals and monoclonal antibody combination therapy in haematological patients in the omicron era Antiviral and monoclonal Antibodies in Haematological Patients in the omicron era
1347PDF: 995HTML: 97 -
-
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1788PDF: 828HTML: 300 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2284PDF: 1363Html: 351 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1150PDF: 1267HTML: 118 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3174PDF: 925HTML: 7303Kost Fig1: 210Kost Fig 2: 198Kost Fig3: 204Kost Fig 4: 215Kost Fig5: 214Kost fig 6: 201 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2555HTML: 303PDF: 940 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
3090PDF: 1665HTML: 14668Untitled: 234Untitled: 195







